Delivery Order SPE2DB22D3501-SPE2DB24FWA45

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a pharmaceutical product, with a ceiling value of $1,942.40. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is a delivery order with a firm fixed price of $2,444.61 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the supply of NORDITROPIN FLEXPRO 15 MG/1.5 1.5ML medical products, with a period of performance through June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen Drug Corp with the DLA, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,602.78 firm fixed-price delivery order is for the supply of 4567317362 NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML medical products. The contract has an ultimate completion date of February 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,783.15 firm fixed-price delivery order is for the supply of NORDITROPIN FLEXPRO 5 MG/1.5 1.5ML medical products, with an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $2,095.38, is for the delivery of Norditropin FlexPro 15 mg/1.5 ml medical devices. It is a Firm Fixed Price Delivery Order contract with a period of performance through March 3, 2025. The contract is not designated as a set-aside and represents open competition. AmerisourceBergen...
This federal contract award, valued at $1,164.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a medical product, with a completion date of June 10, 2025. This is a firm fixed-price delivery order contract, and it is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,534.14 delivery order contract is for the supply of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a specialty medication. The contract has a firm fixed price pricing type and a period of performance through February 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,095.29, is a delivery order for the supply of NORDITROPIN FLEXPRO 10 MG/1.5 1.5ML, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award is for the delivery of Norditropin FlexPro 15 mg/1.5 ml pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Norditropin FlexPro 30 mg/3 mL medical devices. The contract, valued at $7,014.24, was awarded on May 23, 2022, with a completion date of May 24, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWA45
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of Norditropin Flexpro medical devices, valued at $4,318.87. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:04 AM